Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06479876 · ClinicalTrials.gov registry record · NA

Home-Based Cardiac Rehabilitation for Patients With Heart Failure

A NA study of Cardiovascular Diseases and Heart Failure With Preserved Ejection Fraction, sponsored by Vanderbilt University Medical Center.

Recruiting
Registry status
NA
Development phase
100
Enrollment target
1
Study location

NCT06479876 is a NA study of Cardiovascular Diseases and Heart Failure With Preserved Ejection Fraction that is actively recruiting participants, run by Vanderbilt University Medical Center. The registered enrollment target is 100 participants, below the 26,974-participant average among 300 other Cardiovascular Diseases trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06479876, a NA study of Cardiovascular Diseases and Heart Failure With Preserved Ejection Fraction, is actively recruiting participants, sponsored by Vanderbilt University Medical Center.

RECRUITING
Registry status
NA
Development phase
100 participants
Enrollment target
1
Study location

Study Summary

The vast majority of individuals with heart failure do not participate in center based cardiac rehabilitation (CBCR). While steps to increase utilization of CBCR are important, many individuals will still not participate for a variety of reasons. This pilot randomized controlled trial is evaluating a home-based cardiac rehabilitation (HBCR) intervention delivered using a custom app and digital tools in patients with heart failure. After a brief roll-in period, participants are randomized to one of two groups: (1) control or (2) HBCR mobile health intervention. The intervention targets key health behaviors and includes traditional cardiac rehabilitation components. The study will assess the effect of the intervention on physical activity, quality of life, clinical events, and other outcomes.

Conditions Studied

Cardiovascular Diseases Heart Failure With Preserved Ejection Fraction Heart Failure With Reduced Ejection Fraction

Interventions

  • OTHER HBCR

Study Locations (1)

Tennessee

  • Vanderbilt University Medical Center - Nashville

Trial Details

FieldValue
Enrollment Target 100 participants
Start Date 2024-08-05
Est. Completion 2026-08
Phase NA

Sponsor

Vanderbilt University Medical Center

677 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT06479876

The ClinicalTrials.gov registry entry for NCT06479876 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 100 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 26,974-participant average among 300 other Cardiovascular Diseases trials with a reported enrollment target (100% lower). The listed sponsor is Vanderbilt University Medical Center, which has 677 total studies on file at ClinicalTrials.gov.

The record links to 3 conditions, with Cardiovascular Diseases appearing as the primary indexed condition, and to 1 intervention - of which HBCR is the first listed.

NCT06479876 reports 1 study location spanning 1 distinct geographic area - top geographies include Tennessee.

Frequently Asked Questions

What is clinical trial NCT06479876 about?

NCT06479876 is a clinical study titled "Home-Based Cardiac Rehabilitation for Patients With Heart Failure". The vast majority of individuals with heart failure do not participate in center based cardiac rehabilitation (CBCR). While steps to increase utilization of CBCR are important, many individuals will still not participate for a variety of reasons. This pilot randomized controlled trial is evaluating ...

What is the current status of trial NCT06479876?

This trial is currently recruiting. It is a NA study. The enrollment target is 100 participants. The study started on 2024-08-05. Estimated completion is 2026-08.

What conditions does trial NCT06479876 study?

This clinical trial studies the following conditions: Cardiovascular Diseases, Heart Failure With Preserved Ejection Fraction, Heart Failure With Reduced Ejection Fraction.

What interventions are being tested in trial NCT06479876?

The interventions under investigation include: HBCR (OTHER).

Who is sponsoring clinical trial NCT06479876?

This trial is sponsored by Vanderbilt University Medical Center, which has 677 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06479876 being conducted?

This trial has 1 study location across Tennessee. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Cardiovascular Diseases

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Cardiovascular Diseases

All registered trials for this condition

Heart Failure With Preserved Ejection Fraction

All registered trials for this condition

Tennessee

All trials with a study site in Tennessee

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.